<DOC>
	<DOCNO>NCT00423605</DOCNO>
	<brief_summary>The objective trial evaluate safety efficacy Xyrem® long term use .</brief_summary>
	<brief_title>Safety Efficacy Study Xyrem® ( Sodium Oxybate ) Subjects With Fibromyalgia .</brief_title>
	<detailed_description>The trial open-label safety efficacy study subject fibromyalgia complete either study 06-008 06-009 . Total duration 40 week trial participation .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Sodium Oxybate</mesh_term>
	<criteria>Subject qualify complete either study 06009 ( NCT00423813 ) 06008 ( NCT00371137 ) . Subject able , opinion investigator , take Xyrem® approximately 91/2 month . Subject terminate early either study 06009 06008 . Subject experience serious adverse event relate study drug either study 06009 06008 . Subject , opinion investigator , experience adverse event 06009 06008 may prevent him/her safely participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>FMS</keyword>
	<keyword>Fibro</keyword>
	<keyword>Pain</keyword>
	<keyword>Body Pain</keyword>
	<keyword>Tenderness</keyword>
	<keyword>Joint pain</keyword>
	<keyword>Stiffness</keyword>
	<keyword>Muscular Pain</keyword>
</DOC>